-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dazostinag in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dazostinag in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dazostinag in Solid Tumor Drug Details: TAK-676 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tanimilast in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tanimilast in Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tanimilast in Asthma Drug Details: Tanimilast (CHF-6001) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACD-440 in Neuropathic Pain (Neuralgia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACD-440 in Neuropathic Pain (Neuralgia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACD-440 in Neuropathic Pain (Neuralgia) Drug Details: ACD-440 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dazostinag in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dazostinag in Oropharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dazostinag in Oropharyngeal Cancer Drug Details: TAK-676 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Travoprost ER in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Travoprost ER in Ocular Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Travoprost ER in Ocular Hypertension Drug Details: Travoprost extended release...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tanimilast in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tanimilast in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tanimilast in Chronic Obstructive Pulmonary Disease (COPD) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tanimilast in Chronic Bronchitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tanimilast in Chronic Bronchitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tanimilast in Chronic Bronchitis Drug Details: Tanimilast (CHF-6001) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zorevunersen Sodium in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zorevunersen Sodium in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zorevunersen Sodium in Dravet Syndrome...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Salutaxel in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Salutaxel in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salutaxel in Ovarian Cancer Drug Details: Salutaxel is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Salutaxel in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Salutaxel in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salutaxel in Prostate Cancer Drug Details: Salutaxel is under development for...